Marshall Wace North America’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $6.8M | Buy |
53,625
+29,099
| +119% | +$3.69M | 0.03% | 431 |
|
|
2021
Q2 | $4.08M | Sell |
24,526
-58,765
| -71% | -$9.77M | 0.02% | 601 |
|
|
2021
Q1 | $15.1M | Buy |
83,291
+71,231
| +591% | +$12.9M | 0.06% | 316 |
|
|
2020
Q4 | $2.41M | Buy |
12,060
+7,249
| +151% | +$1.45M | 0.01% | 705 |
|
|
2020
Q3 | $1.06M | Buy |
+4,811
| New | +$1.06M | 0.01% | 786 |
|
|
2020
Q2 | – | Sell |
-8,346
| Closed | -$1.29M | – | 1472 |
|
|
2020
Q1 | $1.29M | Buy |
+8,346
| New | +$1.29M | 0.01% | 567 |
|
|
2019
Q3 | – | Sell |
-34,926
| Closed | -$2.32M | – | 1546 |
|
|
2019
Q2 | $2.32M | Buy |
34,926
+34,296
| +5,444% | +$2.28M | 0.01% | 533 |
|
|
2019
Q1 | $35K | Buy |
+630
| New | +$35K | ﹤0.01% | 1318 |
|
|
2018
Q4 | – | Sell |
-202,001
| Closed | -$17.4M | – | 1629 |
|
|
2018
Q3 | $17.4M | Buy |
202,001
+153,146
| +313% | +$13.2M | 0.12% | 152 |
|
|
2018
Q2 | $2.84M | Buy |
+48,855
| New | +$2.84M | 0.02% | 675 |
|
|
2017
Q4 | – | Sell |
-113,562
| Closed | -$3.75M | – | 1602 |
|
|
2017
Q3 | $3.75M | Buy |
+113,562
| New | +$3.75M | 0.02% | 628 |
|